Jubilant Pharmova Ltd Analyst Rating
based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 2 analysts offering long term price targets for Jubilant Pharmova Ltd. An average target of ₹1259
Source: S&P Global Market Intelligence
Jubilant Pharmova Ltd Share analysis
Jubilant Pharmova Ltd price forecast by 2 analysts
Upside of11.37%
High
₹1450
Target
₹1259.00
Low
₹1068
Jubilant Pharmova Ltd target price ₹1259, a slight upside of 11.37% compared to current price of ₹1130.35. According to 2 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Jubilant Pharmova Ltd revenue growth forecast
Expected growth rate Q1, FY2026:27.89%
Forecast
Actual
Including amortisation and stock based compensations
Jubilant Pharmova Ltd EPS growth forecast
EPS estimate Q1, FY2026:
Forecast
Actual
Source: S&P Global Market Intelligence
Jubilant Pharmova Ltd Performance
Day's Low
Day's High
₹1,117.5₹1,157.452 Week's Low
52 Week's High
₹409.4₹1,309.9
| Returns % | |
| 1 Month Return | -4.48 % |
| 3 Month Return | + 25.83 % |
| 1 Year Return | + 163.21 % |
| Market Stats | |
| Previous Close | ₹1,130.50 |
| Open | ₹1,128.00 |
| Volume | 1.12L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹18,008.87Cr |
Jubilant Pharmova Ltd Key Statistics
| P/E Ratio | 30.19 |
| PEG Ratio | 0.75 |
| Market Cap | ₹18,008.87 Cr |
| P/B Ratio | 3.81 |
| EPS | 4.6 |
| Dividend Yield | 0.88 |
| Sector | Pharmaceuticals |
| ROE | 1.32 |
Jubilant Pharmova Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹18,008.87 Cr | 29.69% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
| HOLD | ₹32,572.86 Cr | 131.85% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
| NA | ₹6,359.97 Cr | 4.48% | 0.79 | -₹388 Cr | ₹75 Cr | |
| BUY | ₹16,029.93 Cr | 50.12% | 0.68 | ₹218 Cr | ₹1,296 Cr | |
| BUY | ₹26,422.71 Cr | 228.53% | 0.55 | ₹258 Cr | ₹1,375 Cr |
About Jubilant Pharmova Ltd
Share Price: ₹1130.35 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹18,008.87Cr as of today
Revenue: ₹1,742.20Cr as on September 2024 (Q3 24)
Net Profit: ₹102.50Cr as on September 2024 (Q3 24)
Listing date: 09 Nov, 1994
Chairperson Name: Shyam S Bhartia
| Organisation | Jubilant Pharmova Ltd |
| Headquarters | Noida |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Jubilant Pharmova Ltd
Jubilant Pharmova Reports Mixed Q2 Results and Loan Prepayment - 25 Oct, 2024
Jubilant Pharmova's Q2 results show a significant profit increase driven by radiopharmaceuticals, despite a QoQ net profit drop. The company also prepaid a $25 million loan, indicating financial strength.
Nuvama Initiates Buy Rating for Jubilant Pharmova - 07 Oct, 2024
Nuvama Institutional Equities has initiated coverage on Jubilant Pharmova with a 'buy' rating, projecting a 30% price increase to Rs 1,450. The brokerage anticipates significant revenue and profit growth driven by various factors, including product launches and operational improvements, with a potential free cash flow of Rs 1,900 crore by 2027.
FDA Inspection Classifies Jubilant Facility as OAI - 30 Sep, 2024
The US FDA has classified the inspection of Jubilant HollisterStier's Canadian contract manufacturing facility as Official Action Indicated (OAI), indicating potential compliance issues.
Jubilant Pharmova Completes FDA Inspection Successfully - 26 Sep, 2024
Jubilant Pharmova announced the successful completion of an FDA audit of its Spokane facilities. However, shares fell by 2.13% to ₹1,183.90.
Insights on Jubilant Pharmova Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 year, JUBLPHARMA stock has moved up by 163.2%
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, JUBLPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 2.25% to 3.06% in Sep 2024 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 50.68% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 41.6%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 25.18% to 25.17% in Sep 2024 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 19.49% to 17.94% in Sep 2024 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 482.1 Cr → 102.8 Cr (in ₹), with an average decrease of 78.7% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 2.14K Cr → 1.77K Cr (in ₹), with an average decrease of 17.2% per quarter
Jubilant Pharmova Ltd Financials
Index Inclusions
Jubilant Pharmova Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 50.68% | 0.00 | |
| Foreign Institutions | 17.94% | ||
| Mutual Funds | 3.06% | 35.81 | |
| Retail Investors | 25.17% | ||
| Others | 3.16% | 31.44 |
Jubilant Pharmova Ltd Key Indicators
Jubilant Pharmova Ltd Valuation
Jubilant Pharmova Ltd in the last 5 years
Lowest (-195.50x)
December 29, 2023
Today (30.19x)
November 19, 2024
Industry (54.42x)
November 19, 2024
Highest (257.22x)
February 16, 2024
Jubilant Pharmova Ltd Earnings and Dividends
Jubilant Pharmova Ltd Earnings Results
Jubilant Pharmova Ltd’s net profit jumped 64.48% since last year same period to ₹102.80Cr in the Q2 2024-2025. On a quarterly growth basis, Jubilant Pharmova Ltd has generated -78.68% fall in its net profits since last 3-months.
Read More about Earnings ResultsJubilant Pharmova Ltd Dividends May,2024
In the quarter ending March 2024, Jubilant Pharmova Ltd has declared dividend of ₹5 - translating a dividend yield of 0.88%.
Read More about Dividends
Jubilant Pharmova Ltd Technicals Summary
Bearish
Neutral
Bullish
Jubilant Pharmova Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Jubilant Pharmova Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Jubilant Pharmova Ltd shares.
Jubilant Pharmova Ltd (JUBLPHARMA) share price today is ₹1130.35
Jubilant Pharmova Ltd is listed on NSE
Jubilant Pharmova Ltd is listed on BSE
- Today’s highest price of Jubilant Pharmova Ltd is ₹1157.4.
- Today’s lowest price of Jubilant Pharmova Ltd is ₹1117.5.
PE Ratio of Jubilant Pharmova Ltd is 30.19
PE ratio = Jubilant Pharmova Ltd Market price per share / Jubilant Pharmova Ltd Earnings per share
Today’s traded volume of Jubilant Pharmova Ltd(JUBLPHARMA) is 1.12L.
Today’s market capitalisation of Jubilant Pharmova Ltd(JUBLPHARMA) is ₹18008.87Cr.
| Jubilant Pharmova Ltd(JUBLPHARMA | Price |
|---|---|
52 Week High | ₹1309.9 |
52 Week Low | ₹409.4 |
Jubilant Pharmova Ltd(JUBLPHARMA) share price is ₹1130.35. It is down -13.71% from its 52 Week High price of ₹1309.9
Jubilant Pharmova Ltd(JUBLPHARMA) share price is ₹1130.35. It is up 176.10% from its 52 Week Low price of ₹409.4
| Jubilant Pharmova Ltd(JUBLPHARMA | Returns |
|---|---|
1 Day Returns | -0.15% |
1 Month Returns | -4.48% |
3 Month Returns | 25.83% |
1 Year Returns | 163.21% |